R1 RCM INVESTOR ALERT - Kuznicki Law PLLC Investigates R1 RCM Inc. - RCM

May 04, 2022 05:39 pm
CEDARHURST, N.Y. -- 

Kuznicki Law PLLC is investigating the proposed sale of Cloudmed to R1 RCM Inc. (“the Company”) (NasdaqGS: RCM). Under the terms of the proposed transaction, Cloudmed equity holders will own approximately 30% of the combined company. Kuznicki Law is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.

If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-938-0905, via email ([email protected]), or visit https://kclasslaw.com/cases/ma/nasdaqgs-rcm/ to learn more.

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

Kuznicki Law PLLC
Daniel Kuznicki, Esq.
Email: [email protected]
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com